IDEXX Laboratories EVP Sells Over $1 Million in Stock

Nimrata Hunt, an executive vice president at the veterinary diagnostics company, sold nearly 1,800 shares.

Published on Mar. 5, 2026

Got story updates? Submit your updates here. ›

IDEXX Laboratories, Inc. (NASDAQ:IDXX) EVP Nimrata Hunt sold 1,758 shares of the company's stock on March 3rd, 2026 for a total transaction of $1,115,574.06. Following the sale, Hunt still owns 18,141 shares of IDEXX Laboratories stock, valued at approximately $11.5 million.

Why it matters

Insider transactions, such as stock sales by executives, can provide insights into a company's performance and the perspectives of its leadership. This sale by an IDEXX Laboratories EVP represents a notable decrease in their ownership stake, which may signal their views on the company's outlook or stock valuation.

The details

Nimrata Hunt, an executive vice president at IDEXX Laboratories, sold 1,758 shares of the company's stock on March 3rd, 2026. The shares were sold at an average price of $634.57, resulting in a total transaction value of $1,115,574.06. Following the sale, Hunt now directly owns 18,141 shares of IDEXX Laboratories stock, valued at approximately $11.5 million.

  • Nimrata Hunt sold 1,758 shares on March 3rd, 2026.
  • On February 26th, 2026, Hunt sold an additional 2,693 shares.

The players

Nimrata Hunt

An executive vice president at IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc.

A global developer, manufacturer and provider of diagnostic products and services primarily for the animal health, water testing and food safety markets.

Got photos? Submit your photos here. ›

The takeaway

This insider sale by an IDEXX Laboratories executive could signal their views on the company's stock valuation or future prospects, though more context would be needed to fully understand the motivations behind the transaction.